Johnson & Johnson (JNJ)

USD 156.12

(1.07%)

Gross Profit Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual gross profit in 2023 was 58.6 Billion USD , up 5.8% from previous year.
  • Johnson & Johnson's latest quarterly gross profit in 2024 Q3 was 15.68 Billion USD , down -0.45% from previous quarter.
  • Johnson & Johnson reported a annual gross profit of 55.39 Billion USD in annual gross profit 2022, up 0.1% from previous year.
  • Johnson & Johnson reported a annual gross profit of 55.33 Billion USD in annual gross profit 2021, up 2.18% from previous year.
  • Johnson & Johnson reported a quarterly gross profit of 14.87 Billion USD for 2024 Q1, up 1.88% from previous quarter.
  • Johnson & Johnson reported a quarterly gross profit of 15.57 Billion USD for 2024 Q2, up 4.75% from previous quarter.

Annual Gross Profit Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Gross Profit of Johnson & Johnson (2023 - 1989)

Year Gross Profit Gross Profit Growth
2023 58.6 Billion USD 5.8%
2022 55.39 Billion USD 0.1%
2021 55.33 Billion USD 2.18%
2020 54.15 Billion USD -0.63%
2019 54.5 Billion USD 0.02%
2018 54.49 Billion USD 6.64%
2017 51.09 Billion USD 1.77%
2016 50.2 Billion USD 3.43%
2015 48.53 Billion USD -5.91%
2014 51.58 Billion USD 5.34%
2013 48.97 Billion USD 7.47%
2012 45.56 Billion USD 2.01%
2011 44.67 Billion USD 4.38%
2010 42.79 Billion USD -1.51%
2009 43.45 Billion USD -3.95%
2008 45.23 Billion USD 4.37%
2007 43.34 Billion USD 13.27%
2006 38.26 Billion USD 4.67%
2005 36.56 Billion USD 7.76%
2004 33.92 Billion USD 14.28%
2003 29.68 Billion USD 14.84%
2002 25.85 Billion USD 10.15%
2001 23.46 Billion USD 7.69%
2000 21.79 Billion USD 6.45%
1999 20.47 Billion USD 17.21%
1998 17.46 Billion USD 5.58%
1997 16.54 Billion USD 5.98%
1996 15.61 Billion USD 15.95%
1995 13.46 Billion USD 20.66%
1994 11.15 Billion USD 11.99%
1993 9.96 Billion USD 3.41%
1992 9.63 Billion USD 10.29%
1991 8.73 Billion USD 12.45%
1990 7.76 Billion USD 16.11%
1989 6.69 Billion USD 9.71%

Peer Gross Profit Comparison of Johnson & Johnson

Name Gross Profit Gross Profit Difference
AbbVie Inc. 45.53 Billion USD -28.697%
Bristol-Myers Squibb Company 34.31 Billion USD -70.798%
Bristol-Myers Squibb Company Ce 34.31 Billion USD -70.798%
Eli Lilly and Company 27.04 Billion USD -116.723%
Merck & Co., Inc. 43.98 Billion USD -33.229%
Novartis AG 34.18 Billion USD -71.423%
Organon & Co. 3.74 Billion USD -1463.661%
Pfizer Inc. 28.8 Billion USD -103.429%